iSTAR Medical

Belgium - WavreBiotechnology1 H-1B visas (FY2023)

Focus: iSTAR Medical is a Belgium-based biotech company specializing in minimally-invasive glaucoma surgery (MIGS) devices, founded in 2023 with a focused portfolio in ophthalmology. The company operates at pre-revenue stage with a small team developing next-generation glaucoma implant technologies.

Ophthalmology

Profile data last refreshed 7h ago · AI intelligence enriched 2w ago

Open Jobs

About iSTAR Medical

AI assessmentNot Hiring

No open roles listed right now. Follow iSTAR Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

12 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Glaucoma device implantation in a stand-alone procedure

Glaucoma, Open-Angle

N/A

Clinical Trials (1)

NCT03624361MINIject Glaucoma Implant in European Patients

N/A

Help build intelligence for iSTAR Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage opportunity in high-need ophthalmology market where MIGS represents a growing surgical alternative to traditional glaucoma treatments
Multiple device candidates in clinical development (MINIject, STARflo) suggest diversified pipeline and potential for multiple value inflection points
European headquarters with demonstrated H1B sponsorship capability (1 approval, 0 denials in 2023) indicates openness to global talent recruitment

Watch Out For

Founded in 2023 with unknown employee count, funding, and revenue raises material uncertainty about runway, burn rate, and long-term stability
Only 4 active job openings and absence of published data on headcount growth suggest constrained hiring and limited near-term career mobility within the organization

Generated by Claude from iSTAR Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

MIGS

Glaucoma

N/A

Clinical Trials (1)

NCT07009236A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma

N/A

STARflo Implant

Open Angle Glaucoma

N/A

Clinical Trials (1)

NCT02825264STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program

N/A

STARflo Glaucoma Implant

Open Angle Glaucoma

N/A

Clinical Trials (1)

NCT02272569STARflo European Safety and Efficacy Study

N/A

MINIject implant

Open Angle Glaucoma

N/A

Clinical Trials (1)

NCT03193736MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications

N/A

MINIject™ Implant

Glaucoma

N/A

Clinical Trials (1)

NCT05024695Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

N/A

MINI DO636

Open Angle Glaucoma

N/A

Clinical Trials (1)

NCT03374553MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications

N/A

STAR-LIFE: a Post-market Registry on MINIject

Open Angle Glaucoma

N/A

Clinical Trials (1)

NCT05269680STAR-LIFE: a Post-market Registry on MINIject

N/A

Phacoemulsification combined with minimally invasive glaucoma surgery

Primary Open-angle Glaucoma

N/A

Clinical Trials (1)

NCT05432245MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract

N/A

MINIject CS627 implant

Glaucoma, Open-Angle

N/A

Clinical Trials (1)

NCT03996200MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool

N/A

Minimally invasive glaucoma surgery

Open Angle Glaucoma

N/A

Clinical Trials (1)

NCT04524416MINIject Global Long-Term Follow-up Study

N/A

MINIject CS627 implant

Glaucoma, Open-Angle Glaucoma Eye

N/A

Clinical Trials (1)

NCT04517786MINIject (MINI SO627) in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2023

Portfolio: 12 clinical trials

Top TAs: Ophthalmology, Cardiovascular

H-1B (2023): 1 approval

Therapeutic Area Focus

Ophthalmology

12 pipeline

Cardiovascular

1 pipeline

Marketed

Pipeline

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo